Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Juvista: Phase II data

In a double-blind Phase II trial (Trial 1008) in 239 patients undergoing excision of benign head and neck

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE